Page last updated: 2024-10-18

dalteparin and Anemia, Cooley's

dalteparin has been researched along with Anemia, Cooley's in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"Hyperhomocysteinemia is a metabolic disorder caused by various enzyme defects in methionine metabolism."1.51Multifactorial Painful Leg Ulcers Due to Hyperhomocysteinemia, Plasminogen Activator Inhibitor-1 4G/5G Heterozygote Gene Mutation, and Beta Thalassemia Minor: A Case Report. ( Büyükbabani, N; Çaytemel, C; Topaloğlu Demir, F; Türkoğlu, Z; Uzuner, EG, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Çaytemel, C1
Topaloğlu Demir, F1
Büyükbabani, N1
Türkoğlu, Z1
Uzuner, EG1

Other Studies

1 other study available for dalteparin and Anemia, Cooley's

ArticleYear
Multifactorial Painful Leg Ulcers Due to Hyperhomocysteinemia, Plasminogen Activator Inhibitor-1 4G/5G Heterozygote Gene Mutation, and Beta Thalassemia Minor: A Case Report.
    The international journal of lower extremity wounds, 2019, Volume: 18, Issue:3

    Topics: Bandages; beta-Thalassemia; Biopsy; Diagnosis, Differential; Enoxaparin; Fibrinolytic Agents; Humans

2019